Helena Hahn

European Policy Centre (EPC)

European Union, Integration, Migration Governance

Informationen

Main research interests

  • Global migration governance
  • The external dimension of EU migration policy
  • Migration and development
  • EU funding
  • Border security

Helena Hahn joined the EPC in May 2020. She is currently Junior Policy Analyst within the European Diversity and Migration Programme. Her main interests include border management, EU migration cooperation with third countries, EU funding, climate-induced displacement as well as refugee integration policies.

She previously gained experience at the Migration Policy Institute (MPI) in Washington, DC, the Brussels Mission of the International Centre for Migration Policy Development (ICMPD) and the International Organization for Migration (IOM) in Vienna, Austria.

Helena holds a Master in International Affairs (MIA) from the Graduate Institute in Geneva (2019), where she focused on security studies, migration and urban policy. She obtained her Bachelor’s degree in World Politics from Leiden University College The Hague (2016).

In MEDAM, Helena Hahn contributes to the EPC team’s work in providing policy analysis and research output.

Twitter

Avatar des Autors

Helena Hahn

@H__Hahn

This is not so much about stigmatization, but about reassurance, particularly in the absence of achievable goals or shifting timelines for reopening. My hunch? It may be a while before we see a reopening, especially with fall and winter approaching. 3/

Avatar des Autors

Helena Hahn

@H__Hahn

Since there remains much uncertainty around the end of the pandemic, travelers should be able to easily access testing so that they can at least ensure relative safety on the individual level, regardless of what the national/state requirements and health infrastructures are. 2/

Avatar des Autors

Helena Hahn

@H__Hahn

@meghan_benton What is more, differences in requirements (vaccine versus testing, stringent versus less stringent) are also not helping. For mobility to work, the US and EU should jointly agree on criteria, esp. if vaccination rates diverge, as it now looks to be the case (US-63 versus EU>70%).